No connection

Search Results

FTRE vs OPK

FTRE
Fortrea Holdings Inc.
BEARISH
Price
$9.38
Market Cap
$877.0M
Sector
Healthcare
AI Confidence
85%
OPK
OPKO Health, Inc.
BEARISH
Price
$1.18
Market Cap
$905.9M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
FTRE
--
OPK
--
Forward P/E
FTRE
9.91
OPK
-3.58
P/B Ratio
FTRE
1.55
OPK
0.71
P/S Ratio
FTRE
0.32
OPK
1.49
EV/EBITDA
FTRE
43.85
OPK
-7.29

Profitability

Gross Margin
FTRE
18.5%
OPK
13.5%
Operating Margin
FTRE
1.33%
OPK
-28.98%
Profit Margin
FTRE
-36.21%
OPK
-37.19%
ROE
FTRE
-102.41%
OPK
-17.14%
ROA
FTRE
-0.61%
OPK
-6.62%

Growth

Revenue Growth
FTRE
-5.2%
OPK
-19.2%
Earnings Growth
FTRE
--
OPK
--

Financial Health

Debt/Equity
FTRE
1.98
OPK
0.31
Current Ratio
FTRE
0.98
OPK
3.97
Quick Ratio
FTRE
0.87
OPK
3.21

Dividends

Dividend Yield
FTRE
--
OPK
--
Payout Ratio
FTRE
0.0%
OPK
0.0%

AI Verdict

FTRE BEARISH

FTRE exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. While valuation metrics like Price/Sales (0.32) and PEG (0.34) suggest the stock is deeply undervalued, this is offset by negative revenue growth (-5.20%), a negative ROE of -102.41%, and a current ratio below 1.0 (0.98), signaling liquidity risks. Despite a 'Buy' consensus from analysts with a target of $13.21, the combination of C-suite insider selling and a consistent failure to meet earnings estimates suggests a high-risk profile.

Strengths
Very low Price-to-Sales ratio (0.32) suggesting potential deep value
Low PEG ratio (0.34) if growth can be stabilized
Positive analyst sentiment with a target price of $13.21
Risks
Critical financial health (Piotroski F-Score 2/9)
Negative revenue growth both YoY and Q/Q
Liquidity risk with a current ratio of 0.98 and quick ratio of 0.87
OPK BEARISH

OPK exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating critical failures in profitability and operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.97 and low debt, these are offset by a -19.2% decline in year-over-year revenue and deeply negative profit margins. The stock is trading below its book value (P/B 0.71), but the persistent long-term price decay (-72.8% over 5 years) suggests a value trap rather than a bargain. Despite optimistic analyst price targets, the deterministic data points to a company in structural decline.

Strengths
Strong short-term liquidity (Current Ratio 3.97)
Low leverage (Debt/Equity 0.31)
Trading at a discount to book value (P/B 0.71)
Risks
Severe operational weakness (Piotroski F-Score 1/9)
Significant revenue contraction (-19.2% YoY)
Deeply negative profit margins (-37.19%)

Compare Another Pair

FTRE vs OPK: Head-to-Head Comparison

This page compares Fortrea Holdings Inc. (FTRE) and OPKO Health, Inc. (OPK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile